These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29212209)

  • 21. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methanodibenzo[
    Murugesan A; Kari S; Shrestha A; Assoah B; Saravanan KM; Murugesan M; Thiyagarajan R; Candeias NR; Kandhavelu M
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies.
    Nguyen TT; Katt WP; Cerione RA
    Future Drug Discov; 2023 Mar; 4(4):FDD79. PubMed ID: 37009252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells.
    Donadio AC; Lobo C; Tosina M; de la Rosa V; Martín-Rufián M; Campos-Sandoval JA; Matés JM; Márquez J; Alonso FJ; Segura JA
    J Cell Biochem; 2008 Feb; 103(3):800-11. PubMed ID: 17614351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutaminolysis Was Induced by TGF-β1 through PP2Ac Regulated Raf-MEK-ERK Signaling in Endothelial Cells.
    Guo Y; Deng Y; Li X; Ning Y; Lin X; Guo S; Chen M; Han M
    PLoS One; 2016; 11(9):e0162658. PubMed ID: 27612201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
    Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
    Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maximal activity of phosphate-dependent glutaminase and glutamine metabolism in septic rats.
    Ardawi MS; Majzoub MF; Kateilah SM; Newsholme EA
    J Lab Clin Med; 1991 Jul; 118(1):26-32. PubMed ID: 2066639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamine as a precursor for transmitter glutamate, aspartate and GABA in the cerebellum: a role for phosphate-activated glutaminase.
    Holten AT; Gundersen V
    J Neurochem; 2008 Feb; 104(4):1032-42. PubMed ID: 17986214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamine in neoplastic cells: focus on the expression and roles of glutaminases.
    Szeliga M; Obara-Michlewska M
    Neurochem Int; 2009; 55(1-3):71-5. PubMed ID: 19428809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines.
    Sappington DR; Siegel ER; Hiatt G; Desai A; Penney RB; Jamshidi-Parsian A; Griffin RJ; Boysen G
    Biochim Biophys Acta; 2016 Apr; 1860(4):836-43. PubMed ID: 26825773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap.
    Halama A; Suhre K
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activation.
    Meng G; Xia M; Xu C; Yuan D; Schnurr M; Wei J
    Int J Cancer; 2014 Apr; 134(8):1958-71. PubMed ID: 23921958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premature senescence of human endothelial cells induced by inhibition of glutaminase.
    Unterluggauer H; Mazurek S; Lener B; Hütter E; Eigenbrodt E; Zwerschke W; Jansen-Dürr P
    Biogerontology; 2008 Aug; 9(4):247-59. PubMed ID: 18317946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of glutaminase activity and glutamine metabolism.
    Curthoys NP; Watford M
    Annu Rev Nutr; 1995; 15():133-59. PubMed ID: 8527215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines decrease glutaminase expression in human fibroblasts.
    Sarantos P; Abouhamze A; Abcouwer S; Chakrabarti R; Copeland EM; Souba WW
    Surgery; 1994 Aug; 116(2):276-83; discussion 283-4. PubMed ID: 7519362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymes of glutamine metabolism in inflammation associated with skeletal muscle hypertrophy.
    Kelso TB; Shear CR; Max SR
    Am J Physiol; 1989 Dec; 257(6 Pt 1):E885-94. PubMed ID: 2575354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer.
    Zacharias NM; McCullough C; Shanmugavelandy S; Lee J; Lee Y; Dutta P; McHenry J; Nguyen L; Norton W; Jones LW; Bhattacharya PK
    Sci Rep; 2017 Nov; 7(1):16159. PubMed ID: 29170516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
    Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer.
    Xie C; Jin J; Bao X; Zhan WH; Han TY; Gan M; Zhang C; Wang J
    Oncotarget; 2016 Jan; 7(1):610-21. PubMed ID: 26575584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.